Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. In our role as a WHO Collaborating Centre, we provide training, guidance and support to members of the WHO Programme for International Drug Monitoring (WHO PIDM). We also manage VigiBase , the WHO global database of adverse event reports for medicines and vaccines – the largest database of its kind in the world.

  2. Uppsala Monitoring Centre offers a range of self-paced online courses covering different aspects of medicines safety for all skill levels, from beginners to experienced practitioners. Due to maintenance, course enrolments are paused temporarily. Enrolments will be open to the public again on 16 May 2024.

  3. Uppsala Monitoring Centre advances the science of pharmacovigilance and supports medicines and patient safety initiatives all over the world. As a self-funded, mission-driven, non-profit foundation, we work with the World Health Organization and engage stakeholders throughout the global pharmacovigilance community.

  4. Uppsala Monitoring Centre (UMC), located in Uppsala, Sweden, is the field name for the World Health Organization Collaborating Centre for International Drug Monitoring. UMC works by collecting, assessing and communicating information from member countries' national pharmacovigilance centres in regard to the benefits, harm ...

  5. Uppsala Monitoring Centre. Cursos en ingles. Causality assessment of case series Learning objective: To understand the important elements to consider when assessing ...

  6. Uppsala Monitoring Centre (UMC) is an independent foundation that advances the science of pharmacovigilance globally and serves as a WHO Collaborating Centre supporting the WHO Programme for International Drug Monitoring. Website : https://who-umc.org. Country: Sweden. Last evaluation: 2023. Website audience (s):

  7. www.who.int › teams › regulation-prequalificationWHO Collaborative centers

    The Uppsala Monitoring Centre (UMC) was the first WHO Collaborating Centre to be established for pharmacovigilance when, in 1978, the scientific and technical responsibility of the WHO Programme for International Drug Monitoring was transferred to Sweden. The Centre is an independent, self-funded, non-profit organisation.